Compile Data Set for Download or QSAR
maximum 50k data
Found 514 with Last Name = 'kathi' and Initial = 'pk'
TargetCytochrome P450 2C19(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600721(CHEMBL5184419)
Affinity DataIC50:  300nMAssay Description:Inhibition of recombinant CYP2C19 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600731(CHEMBL5178315)
Affinity DataIC50:  1.00E+3nMAssay Description:Inhibition of recombinant CYP2C9 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM538299(US11254663, Example 157)
Affinity DataIC50:  1.00E+3nMAssay Description:Inhibition of recombinant CYP2C19 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM538213(US11254663, Example 10)
Affinity DataIC50:  1.00E+3nMAssay Description:Inhibition of recombinant CYP2C9 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600730(CHEMBL5173549)
Affinity DataIC50:  1.00E+3nMAssay Description:Inhibition of recombinant CYP2C9 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600727(CHEMBL5177647)
Affinity DataIC50:  1.00E+3nMAssay Description:Inhibition of recombinant CYP2C9 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600724(CHEMBL5199184)
Affinity DataIC50:  1.00E+3nMAssay Description:Inhibition of recombinant CYP2C9 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetBile salt export pump(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600733(CHEMBL5182534)
Affinity DataIC50:  1.40E+3nMAssay Description:Inhibition of BSEP (unknown origin)More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetUDP-glucuronosyltransferase 1A1(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600733(CHEMBL5182534)
Affinity DataIC50:  1.50E+3nMAssay Description:Inhibition of human UGT1A1More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600725(CHEMBL5180682)
Affinity DataIC50:  2.00E+3nMAssay Description:Inhibition of recombinant CYP2C19 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600728(CHEMBL5189617)
Affinity DataIC50:  2.00E+3nMAssay Description:Inhibition of recombinant CYP2C9 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM538513(US11254663, Example 440)
Affinity DataIC50:  2.00E+3nMAssay Description:Inhibition of recombinant CYP2C9 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600725(CHEMBL5180682)
Affinity DataIC50:  2.00E+3nMAssay Description:Inhibition of recombinant CYP2C9 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM538277(US11254663, Example 119)
Affinity DataIC50:  3.00E+3nMAssay Description:Inhibition of recombinant CYP2C9 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600733(CHEMBL5182534)
Affinity DataIC50:  4.50E+3nMAssay Description:Inhibition of hERG by patch clamp assayMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600732(CHEMBL5202191)
Affinity DataIC50:  5.00E+3nMAssay Description:Inhibition of recombinant CYP2C9 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600733(CHEMBL5182534)
Affinity DataIC50:  5.00E+3nMAssay Description:Inhibition of recombinant CYP2C9 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600727(CHEMBL5177647)
Affinity DataIC50:  6.00E+3nMAssay Description:Inhibition of recombinant CYP2C19 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600733(CHEMBL5182534)
Affinity DataIC50:  7.00E+3nMAssay Description:Inhibition of recombinant CYP2C19 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hr...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600728(CHEMBL5189617)
Affinity DataIC50:  7.00E+3nMAssay Description:Inhibition of recombinant CYP2C19 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600723(CHEMBL5204648)
Affinity DataIC50:  8.00E+3nMAssay Description:Inhibition of recombinant CYP2C19 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600733(CHEMBL5182534)
Affinity DataIC50:  8.00E+3nMAssay Description:Inhibition of CYP2C9 in human liver microsomes using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs by...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM538513(US11254663, Example 440)
Affinity DataIC50:  8.00E+3nMAssay Description:Inhibition of recombinant CYP2C19 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600723(CHEMBL5204648)
Affinity DataIC50:  8.00E+3nMAssay Description:Inhibition of recombinant CYP2C9 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM538277(US11254663, Example 119)
Affinity DataIC50:  9.00E+3nMAssay Description:Inhibition of recombinant CYP2C19 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600730(CHEMBL5173549)
Affinity DataIC50:  9.00E+3nMAssay Description:Inhibition of recombinant CYP2C19 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600732(CHEMBL5202191)
Affinity DataIC50:  9.00E+3nMAssay Description:Inhibition of recombinant CYP2C19 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600731(CHEMBL5178315)
Affinity DataIC50:  1.00E+4nMAssay Description:Inhibition of recombinant CYP2C19 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600722(CHEMBL5205416)
Affinity DataIC50:  1.30E+4nMAssay Description:Inhibition of recombinant CYP2C19 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetSolute carrier organic anion transporter family member 1B3(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600733(CHEMBL5182534)
Affinity DataIC50:  1.35E+4nMAssay Description:Inhibition of OATP1B3 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM538213(US11254663, Example 10)
Affinity DataIC50:  1.70E+4nMAssay Description:Inhibition of recombinant CYP2C19 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C8(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600733(CHEMBL5182534)
Affinity DataIC50: >2.00E+4nMAssay Description:Inhibition of CYP2C8 in human liver microsomes using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs by...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600733(CHEMBL5182534)
Affinity DataIC50: >2.00E+4nMAssay Description:Inhibition of CYP2D6 in human liver microsomes using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs by...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600733(CHEMBL5182534)
Affinity DataIC50: >2.00E+4nMAssay Description:Inhibition of CYP2C19 in human liver microsomes using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs b...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600733(CHEMBL5182534)
Affinity DataIC50: >2.00E+4nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs by...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600726(CHEMBL5172239)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of recombinant CYP2C19 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600724(CHEMBL5199184)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of recombinant CYP2C19 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600720(CHEMBL5189418)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of recombinant CYP2C19 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600726(CHEMBL5172239)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of recombinant CYP2C9 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600722(CHEMBL5205416)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of recombinant CYP2C9 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600720(CHEMBL5189418)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of recombinant CYP2C9 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Biocon-Bristol Myers Squibb Research And Development Center

Curated by ChEMBL
LigandPNGBDBM50600721(CHEMBL5184419)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of recombinant CYP2C9 (unknown origin) using fluorogenic substrate preincubated for 15 min followed by NADPH addition measured after 2 hrs...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM538099(US11254663, Example 2)
Affinity DataEC50:  3.06E+3nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM538142(US11254663, Example 5)
Affinity DataEC50:  182nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM538145(US11254663, Example 6)
Affinity DataEC50:  135nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM538212(US11254663, Example 9)
Affinity DataEC50:  153nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM538213(US11254663, Example 10)
Affinity DataEC50:  425nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM538214(US11254663, Example 11)
Affinity DataEC50:  282nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM538215(US11254663, Example 16)
Affinity DataEC50:  318nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM538216(US11254663, Example 17)
Affinity DataEC50:  309nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 514 total ) | Next | Last >>
Jump to: